REBECCA IZQUIERDO: Open Payments
NPI 1053601427 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 20 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $262 · 2025 $452
Food & beverage: $353Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $178 |
| Biogen, Inc. | 5 | $92 |
| Exeltis, USA Inc. | 4 | $70 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $70 |
| Organon LLC | 2 | $41 |
Products named: ZURZUVAE, Veozah, SLYND, NEXPLANON.
Industry payments across TX — which companies pay providers there.
